Delivery Order VA69D17D0031-36C25218N1011

The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Myriad Genetics Inc. for $154,938.00 to provide Prolaris genetic testing services. Prolaris is a molecular diagnostic test that measures gene expression levels to assess prostate cancer aggressiveness. This contract is for the VA Long Beach Healthcare System to utilize Myriad's Prolaris testing capabilities on an as-needed basis from...

This federal contract award with ID HT001417A0029|HT001419F0321 was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company, for Myriad's Prolaris genetic testing services. The $100,000.00 firm-fixed-price contract is for quantitative PCR analysis and reporting to assess prostate cancer aggressiveness and guide treatment approaches. This appears to be a Blanket Purchase Agreement (BPA) call, with Myriad Genetics having been awarded multiple prior BPA calls...

This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration was granted to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide Prolaris prostate cancer testing services. The firm fixed price contract, valued at $14,994.00, is a Blanket Purchase Agreement (BPA) call to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network (VISN) 19 in Salt Lake...

This federal contract award to Myriad Genetics Inc. is for a Blanket Purchase Agreement (BPA) call valued at $100,000 to provide genetic testing services related to cancer diagnostics and risk assessment. The contract was awarded by the Defense Health Agency, a component of the Department of Defense, to deliver Myriad's Prolaris quantitative PCR testing on prostate biopsy samples. The Prolaris test helps assess tumor aggressiveness and guide treatment approaches for prostate cancer patients....

This is a federal contract award from the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract is for the provision of Prolaris prostate cancer testing services to the VA's Salt Lake City VA Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $2,499. The contract has no set-aside designation. This BPA is part of a larger Indefinite Delivery Vehicle (IDV) awarded by the VA's...

This is a firm fixed price delivery order awarded to Myriad Genetic Laboratories Inc., a leading genetic testing and precision medicine company, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $10,982 contract is for the provision of Prolaris prostate cancer testing services to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network 12. Myriad Genetic Laboratories previously held a $149,600...

This is a $497,301.00 firm-fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) to Myriad Genetics Inc. for Prolaris genetic testing services for the VA Long Beach Healthcare System. The contract has a period of performance from October 1, 2024 to September 30, 2027, with no set-aside designation. The original solicitation was a full and open competition for Prolaris send-out testing kits and services to test for prostate cancer. The contract will provide these...

This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Myriad RBM, Inc., a subsidiary of Myriad Genetics, Inc. The $10,157.40 contract is for the provision of Myriad's Prolaris quantitative PCR testing services to assess prostate cancer tumor aggressiveness and guide treatment approaches. No set-aside designation was mentioned. Myriad Genetics, a...

The U.S. Department of the Navy, Bureau of Medicine and Surgery awarded a $87,940.80 firm fixed price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for "THROSEQ V.2 GENETIC MAIL OUT TESTING" and "SPRIOCHETE GENETIC MAIL OUT TESTING" services. The contract has a period of performance from June 25, 2019 to September 30, 2020. This procurement was conducted on an unrestricted, full and open competition basis and was not set aside for any special...

This $122,672 federal contract was awarded by the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract is for the delivery of Prolaris prostate cancer testing services, which analyze genetic information to determine disease progression risks and support clinical treatment decisions. The contract was competitively awarded without a set-aside designation, and is structured...